RECENT WEBINARS
Harnessing Potential: Innovations And Improvements In Viral Gene Therapy
Review the potential of AAV-mediated gene therapy as a platform approach to treat multiple genetic neurological diseases, and explore suggestions to streamline translational studies and reduce costs.
Transforming Rare Disease Drug Development For A Faster Cure
This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.
Optimize Your Process For Producing High-Concentration Drugs
Explore the challenges and solutions in high-concentration monoclonal antibody manufacturing, which includes practical strategies for maximizing product recovery and optimizing processes for efficient production.
Optimal Tech For Predicting Drug Responses At The Cellular Level
Explore how preserving spatial molecular information and leveraging AI-driven spatial-omics can transform treatment prediction, patient stratification, and personalized medicine.
Minimizing Risk In RNA-LNP Encapsulation And Drug Product Manufacturing
Learn about an integrated drug substance/drug product offering for your IND program and beyond, with a holistic approach to ensure process robustness at every stage.
Shifting Drug Development With Advanced Analytical Characterization
Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.
Who's In Charge? How To Ensure Effective Trial Oversight, Leadership
Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
Rapid Delivery Of Toxicological Study Material: Accelerating Development
Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.
How High Drug Load Nanocrystalline Tablets Lower Pill Burden
We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.
Human Factors Testing: Engaging End-Users In Med Device Development
Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.
Get $mart: 1 Year Out From Phase 1 Injectable Trials, Avoid 3 Expensive Mistakes
Learn how to scale up injectable drug production for Phase 1 trials, avoid costly mistakes, and find the right CDMO partner for long-term success.
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
Discovery Through Commercialization: A Biologic Drug's Analytical Journey
Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.
From Research To Reality: Overcoming CMC Challenges In Cell & Gene Therapy
Explore the importance of adopting a Quality by Design (QbD) approach in the development process while integrating regulatory and CMC strategies for maximum efficiency and benefit.
De-Risking Early Phase Micronization With Integrated Solid Form Selection
Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.
Contract Manufacturing: Must-Know Trends And Strategies For 2025
Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.
Essential Considerations For Selecting The Right Biologic Fill/Finish Partner
Partnering with a provider that prioritizes quality and yield optimization not only ensures product safety but also helps reduce operational costs.
CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs
In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.
The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies
Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.
Accelerating Clinical Development: Modern Tools In Process Chemistry
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
Growing A Sustainability Culture Across An Expanding CDMO Network
Peter Skals, Head of Global Sustainability, shares how the company is integrating its climate and ESG strategy while simultaneously expanding its CDMO network and reducing its CO2 footprint.
Demystifying Large Scale Continuous Chromatography For Small Molecules
Learn the fundamentals of developing a continuous chromatography process with Simulated Moving Bed (SMB) technology for small molecules, from gram-scale to multi-ton commercial production.
Project Delivery Methodology To Accelerate Operational Readiness
Learn how to implement a focused operational readiness model that goes beyond traditional construction and startup schedules. Discover how this approach can reduce timelines and improve project success.
Uncovering The Root Cause Of Clinical Trial Troubles
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
Navigating Primary Packaging Challenges, Solutions For Emerging Innovators
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Leveraging Platform Processes For Developing And Accelerating Novel Gene And Cancer Therapeutics
Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.
Removing The Headache: Outsourced Stability Storage And Testing Solutions
Should you manage certain operations internally or partner with a trusted external provider? Watch experts discuss the benefits of outsourcing stability, storage, and testing.
Charting A Successful CMC Journey For Your ADC Drug Product
These real-world case studies highlight best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in the clinical or commercial phase.
Early Preclinical Development: A Successful Transition To cGMP Manufacturing
Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.
How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms
Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.